Human immunodeficiency virus-1 infection protects against a Tc1-to-Tc2 shift in CD8 + T cells

Human Immunology

Volumn 72, Issue 11, 2011, Pages 995-1000

  Gulzar, Naveed ^a   Diker, Bilge ^b   Balasubramanian, Sowmya ^a   Jiang, Janina Q ^a   Copeland, Karen F T ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

CD8 + T cells; Chemokine; Cytokine; HIV 1; Tc1; Tc2

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY INTERLEUKIN 12; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; T-LYMPHOCYTE SUBSETS; TH1-TH2 BALANCE; VIRUS REPLICATION;

EID: 80054113709     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.08.012     Document Type: Article

References (50)

1. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563-1566.
2. Ojo-Amaize E.A., Nishanian P., Keith D.E., Houghton R.L., Heitjan D.F., Fahey J.L., et al. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol 1987, 139:2458-2463.
3. Ljunggren K., Böttiger B., Biberfeld G., Fenyö E.M., Karlson A., Jondal M. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol 1987, 139:2263-2267.
4. Creemers P.C., Stark D.F., Boyko W.J. Evaluation of natural killer cell activity in patients with persistent generalized lymphadenopathy and acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1985, 36:141-150.
5. Senaldi G., Peakman M., McManus T., Davies E.T., Tee D.E., Vergani D. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 1990, 162:1227-1232.
6. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression. Nat Med 1997, 3:659-664.
7. Maciaszek J.W., Parada N.A., Cruikshank W.W., Center D.M., Kornfeld H., Viglianti G.A. IL-16 represses HIV-1 promoter activity. J Immunol 1997, 158:5-8.
8. + T cells. Science 1995, 270:1811-1815.
9. Fauci A.S. Host factors and the pathogenesis of HIV-induced disease. Nature 1996, 384:529-534.
10. Clerici M., Shearer G.M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993, 14:107-111.
11. Clerici M., Hakim F.T., Venzon D.J., Blatt S., Hendrix C.W., Wynn T.A., et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993, 91:759-765.
12. Wagner L., Yang O.O., Garcia-Zepeda E.A., Ge Y., Kalams S.A., Walker B.D., et al. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 1998, 391:908-911.
13. + T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci U S A 2000, 97:13812-13817.
14. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
15. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
16. + T-cell lines vs. primary macrophages. Proc Natl Acad Sci U S A 1995, 92:9004-9008.
17. Emilie D., Maillot M.C., Nicolas J.F., Fior R., Galanaud P. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat. J Biol Chem 1992, 267:20565-20570.
18. Hartshorn K.L., Neumeyer D., Vogt M.W., Schooley R.T., Hirsch M.S. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses 1987, 3:125-133.
19. + T cells that coexpresses CD4 on its surface. Blood 2009, 114:3841-3853.
20. Shrikant P.A., Rao R., Li Q., Kesterson J., Eppolito C., Mischo A., et al. Regulating functional cell fates in CD8 T cells. Immunol Res 2011, 46:12-22.
21. Akerele T., Galatowicz G., Bunce C., Calder V., Lynn W.A., Lightman S. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy. Clin Immunol 2006, 121:191-197.
22. Burton C.T., Gotch F., Imami N. Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: concomitant assessment of perforin, IFN-gamma and IL-4 secretion. J Immunol Methods 2006, 308:216-230.
23. D'Offizi G., Gioia C., Corpolongo A., Martini F., Paganelli R., Volpi I., et al. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects. Int J Immunopathol Pharmacol 2007, 20:473-485.
24. + Memory T-cells by HIV-1 and their proliferative response. Open AIDS J 2008, 2:43-57.
25. Semenzato G., Agostini C., Chieco-Bianchi L., De Rossi A. HIV load in highly purified CD8+ T cells retrieved from pulmonary and blood compartments. J Leukoc Biol 1998, 64:298-301.
26. + T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood 1995, 85:2308-2314.
27. Hughes G.J., Willey S.J., Cochrane A., Leen C., Bell J.E., Simmonds P. Virus immunocapture provides evidence of CD8 lymphocyte-derived HIV-1 in vivo. AIDS 2007, 21:1507-1513.
28. Lee S., Goldstein H., Baseler M., Adelsberger J., Golding H. Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes. J Virol 1997, 71:6671-6676.
29. Cochrane A., Imlach S., Leen C., Scott G., Kennedy D., Simmonds P. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo. J Virol 2004, 78:9862-9871.
30. + T cells during HAART. Virology 2003, 305:339-352.
31. Livingstone W.J., Moore M., Innes D., Bell J.E., Simmonds P. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet 1996, 348:649-654.
32. Agostini C., Trentin L., Sancetta R., Facco M., Tassinari C., Cerutti A., et al. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood 1997, 90:1115-1123.
33. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994, 180:1395-1403.
34. + T cells from human immunodeficiency virus-infected individuals. Blood 1997, 89:3672-3681.
35. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8:345-350.
36. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998, 72:876-881.
37. Fujiwara M., Takata H., Oka S., Tomiyama H., Takiguchi M. Patterns of cytokine production in human immunodeficiency virus type 1 (HIV-1)-specific human CD8+ T cells after stimulation with HIV-1-infected CD4+ T cells. J Virol 2005, 79:12536-12543.
38. Kemp R.A., Backstrom B.T., Ronchese F. The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity. Immunology 2005, 115:315-324.
39. Gulzar N., Diker B., Mihowich J., Deschatelets J., Arsenault M.E., Lamoureux N., et al. Proportion of HIV-1 infected CD8+CD4- T lymphocytes in vivo. Curr HIV Res 2008, 6:585-596.
40. Sad S., Marcotte R., Mosmann T.R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995, 2:271-279.
41. Maggi E., Giudizi M.G., Biagiotti R., Annunziato F., Manetti R., Piccinni M.P., et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994, 180:489-495.
42. Kim J.J., Nottingham L.K., Sin J.I., Tsai A., Morrison L., Oh J., et al. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest 1998, 102:1112-1124.
43. Klein S.A., Dobmeyer J.M., Dobmeyer T.S., Pape M., Ottmann O.G., Helm E.B., et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997, 11:1111-1118.
44. + T lymphocytes producing Th2-type cytokines (Tc2) in HIV-infected individuals. J Biol Regul Homeost Agents 1995, 9:78-81.
45. Maggi E., Giudizi M.G., Biagiotti R., Annunziato F., Manetti R., Piccinni M.P., et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994, 180:489-495.
46. + T cell response by reducing Th1 cytokines and CCR5 ligand secretion. J Acquir Immune Defic Syndr 2011, 58:9-17.
47. Fevrier M., le Borgne S., Marty C., Talarmin A., Riviere Y. Functional characterization of human Tc0, Tc1 and Tc2 CD8+ T cell clones: control of X4 and R5 HIV strain replication. J Clin Immunol 2004, 24:272-280.
48. Osakwe C.E., Bleotu C., Chifiriuc M.C., Grancea C., Otelea D., Paraschiv S., et al. TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy. Roum Arch Microbiol Immunol 2010, 69:24-34.
49. Pohling J., Zipperlen K., Hollett N.A., Gallant M.E., Grant M.D. Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy. BMC Infect Dis 2010, 10:129.
50. Barbour J.D., Ndhlovu L.C., Xuan Tan Q., Ho T., Epling L., Bredt B.M., et al. High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One 2009, 4:e4408.